Stockholm - Delayed Quote • SEK
Vitrolife AB (publ) (VITR.ST)
At close: April 25 at 5:29 PM GMT+2
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 5 | 5 |
| Avg. Estimate | 1.09 | 1.04 | 4.03 | 4.9 |
| Low Estimate | 0.97 | 0.9 | 3.7 | 4.49 |
| High Estimate | 1.29 | 1.26 | 4.77 | 5.74 |
| Year Ago EPS | 0.78 | 0.9 | 3.31 | 4.03 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | 924.5M | 914.75M | 3.65B | 3.96B |
| Low Estimate | 887M | 876M | 3.53B | 3.8B |
| High Estimate | 965M | 954M | 3.79B | 4.22B |
| Year Ago Sales | 925.9M | 872.2M | 3.51B | 3.65B |
| Sales Growth (year/est) | -0.20% | 4.90% | 3.80% | 8.70% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.04 | 0.79 | 1.02 | 0.92 |
| EPS Actual | 0.78 | 0.9 | 0.89 | 0.85 |
| Difference | -0.26 | 0.11 | -0.13 | -0.07 |
| Surprise % | -25.00% | 13.90% | -12.70% | -7.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.09 | 1.04 | 4.03 | 4.9 |
| 7 Days Ago | 1.15 | 1.08 | 4.25 | 5.2 |
| 30 Days Ago | 1.08 | 0.99 | 4.75 | 5.05 |
| 60 Days Ago | 1.08 | 0.99 | 4.75 | 5.05 |
| 90 Days Ago | 1.07 | 0 | 4.34 | 5.25 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 3 | 2 | 4 | 5 |
Growth Estimates
| CURRENCY IN USD | VITR.ST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 39.70% | -- | -- | 2.60% |
| Next Qtr. | 15.60% | -- | -- | 13.40% |
| Current Year | 21.80% | -- | -- | 5.20% |
| Next Year | 21.60% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 15.80% | -- | -- | 11.11% |
| Past 5 Years (per annum) | 2.13% | -- | -- | -- |
Research Analysis
Related Tickers
XVIVO.ST Xvivo Perfusion AB (publ)
356.50
-3.26%
CHEMM.CO ChemoMetec A/S
282.40
-0.77%
BICO.ST BICO Group AB (publ)
44.32
-0.67%
GN.CO GN Store Nord A/S
179.00
-4.71%
MEDI.OL Medistim ASA
174.00
-4.40%
ACARIX.ST Acarix AB (publ)
0.2325
-1.06%
3XV.F Xvivo Perfusion AB
30.55
+7.95%
0MR5.IL CellaVision AB (publ)
231.00
-4.05%
GETI-B.ST Getinge AB (publ)
229.20
-1.33%
CLVSF CellaVision AB (publ)
20.36
0.00%